Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Wroclaw
Clinical trial register · Poland

Clinical Trials in Wroclaw, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Poland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2705 matching records held by the registry are in this view. Synced 28 Oct 2026, 03:18 UTC
2705
Studies in scope
all four open statuses
1389
Recruiting now
open to new participants
512
Lead sponsors
across recruiting studies
Top sites
Warsaw 1315 Krakow 882 Poznan 705 Gdansk 657 Lodz 619
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Wroclaw Medical University30 Pfizer29 AstraZeneca26 Eli Lilly and Company22 Janssen Research & Development, LLC20
Site location
Warsaw1315 Krakow882 Poznan705 Gdansk657 Lodz619
All 264 locations
Target enrolment
to

Trials with a site in Wroclaw

527 of 2705 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Poland
Start
Active, closed
AstraZeneca
Phase 3
1,018
Bialystok, Gdansk, Grudziądz, Koszalin, Piotrkow Trybunalski, Poznan, Warsaw, Wroclaw
2018-05-14
Active, closed
Merck Sharp & Dohme LLC
Phase 3
797
Poznan, Bydgoszcz, Bystra, Wroclaw, Prabuty, Lodz
2018-04-24
Active, closed
AbbVie
Phase 3
1,336
Poznan, Torun, Wroclaw, Lublin, Warsaw, Rzeszów, Chojnice, Tychy
2018-04-09
Active, closed
Janssen Research & Development, LLC
Phase 3
629
Bydgoszcz, Warsaw, Wroclaw
2018-03-23
Active, closed
AbbVie
Phase 3
747
Krakow, Wroclaw, Warsaw
2018-03-21
Recruiting
Charite University, Berlin, Germany
Phase 2
250
Wroclaw
2017-09-01
Active, closed
Eli Lilly and Company
Phase 3
5,637
Konin, Poznan, Wroclaw, Lublin, Warsaw, Opole, Gdansk, Gdynia
2017-07-12
Active, closed
Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation
NCT03173248Newly Diagnosed Acute Myeloid Leukemia (AML), Untreated AML, AML Arising From Myelodysplastic Syndrome (MDS), Leukemia, Myeloid, Acute
DrugsIvosidenib·Azacitidine
Institut de Recherches Internationales Servier
Phase 3
146
Wroclaw, Warsaw, Gdansk
2017-06-26
By invitation
Selected Disorders and Sleep Bruxism
NCT03083405Sleep Bruxism, Hypertension, Thyroid Dysfunction, Mental Status Change
Wroclaw Medical University
Observational
100
Wroclaw
2017-04-20
Active, closed
Acerta Pharma BV
Phase 3
635
Chorzów, Krakow, Lodz, Lublin, Olsztyn, Warsaw, Woj. Podkarpackie, Wroclaw
2017-04-05
Active, closed
AbbVie
Phase 3
443
Krakow, Wroclaw, Chorzów
2017-02-02
Active, closed
AstraZeneca
Phase 3
669
Bialystok, Grudziądz, Koszalin, Lublin, Mrozy, Warsaw, Wroclaw
2017-01-02
Active, closed
Astellas Pharma Global Development, Inc.
Phase 2
900
Gdansk, Mysłowice, Pozman, Słupsk, Warsaw, Wroclaw
2016-12-22
Active, closed
Geron Corporation
Phase 2/3
289
Wroclaw, Słupsk, Poznan, Olsztyn, Piła
2016-01-12
Active, closed
AbbVie
Phase 3
1,629
Torun, Cracow, Krakow, Wroclaw, Lublin, Grodzisk Mazowiecki, Warsaw, Bialystok
2015-12-01
Active, closed
Bayer
Phase 3
24
Wroclaw
2015-10-29
Active, closed
Regeneron Pharmaceuticals
Phase 3
880
Ostrowiec Świętokrzyski, Wroclaw, Krakow, Katowice, Bialystok, Bydgoszcz, Chorzów, Gdansk
2015-10-15
Active, closed
CINC424A2X01B Rollover Protocol
NCT02386800Primary Myelofibrosis, Polycythemia Vera, Graft Versus Host Disease, Acute Myeloid Leukemia
DrugsPanobinostat·Jakavi·Ruxolitinib
Novartis Pharmaceuticals
Phase 4
279
Gliwice, Wroclaw
2015-03-05
Active, closed
Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
NCT02319837Hormone Sensitive Prostate Cancer, Prostate Cancer, Cancer of the Prostate
DrugsLupron·Eligard·Leuprorelin·Xtandi
Pfizer
Phase 3
1,068
Wroclaw, Torun, Gdansk, Słupsk
2014-12-17
Active, closed
Karyopharm Therapeutics Inc
Phase 2
244
Wroclaw, Gdynia, Krakow, Legnica, Lodz, Lublin, Olsztyn, Warsaw
2014-11
Active, closed
A Long-term Extension Study of PCI-32765 (Ibrutinib)
NCT01804686Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma
DrugIbrutinib
Janssen Research & Development, LLC
Phase 3
539
Brzozów, Chorzów, Gdansk, Klinika Nowotworow Ukladu Chlonnego, Krakow, Opole, Słupsk, Wroclaw
2013-09-09
Active, closed
Novartis Pharmaceuticals
Phase 3
240
Lodz, Lublin, Poznan, Wroclaw
2013-07-26
Recruiting
St. Anna Kinderkrebsforschung
Phase 2/3
1,800
Bydgoszcz, Krakow, Lublin, Poznan, Wroclaw
2013-04
Active, closed
Long-term Observation of Ophthalmic Changes in Patients With Obstructive Sleep Apnea
NCT03928665Sleep Apnea, Glaucoma, Ocular Hypertension
Wroclaw Medical University
Observational
150
Wroclaw
2012-10-01
Recruiting
International Chronic Myeloid Leukemia Pediatric Study
NCT01281735Chronic Myeloid Leukemia
Poitiers University Hospital
Observational
750
Wroclaw
2011-01
Recruiting
Prospective Urban Rural Epidemiology Study
NCT03225586Cardiovascular Diseases, Risk Factor, Cardiovascular, Health Behavior, Environmental Exposure
Population Health Research Institute
Observational
200,000
Wroclaw
2002-01-01
By invitation
Copenhagen University Hospital, Rigshospitalet
Observational
23,000
Bialystok, Chorzów, Gdansk, Lodz, Poznan, Szczecin, Warsaw, Wroclaw
1994-01
Rows per page Showing 501–527 of 527
Previous 1 2
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Polish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 29 October 2026. https://priyalifescience.com/clinical-trials-poland/city/wroclaw?page=2

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Poland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,705 studies in total at the last sync on 28 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 527 of those studies with a site in Wroclaw.

How many clinical trials are recruiting in Wroclaw?

252 of the 527 studies on this page are recruiting new participants as of the 28 Oct 2026, 03:18 UTC sync. A further 24 have not yet opened recruitment, 231 are active but closed to new participants, and 20 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.